These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 22682331

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Coagulant effects of black snake (Pseudechis spp.) venoms and in vitro efficacy of commercial antivenom.
    Lane J, O'Leary MA, Isbister GK.
    Toxicon; 2011 Sep 01; 58(3):239-46. PubMed ID: 21723878
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Species differences in the neuromuscular activity of post-synaptic neurotoxins from two Australian black snakes (Pseudechis porphyriacus and Pseudechis colletti).
    Hart AJ, Isbister GK, O'Donnell P, Williamson NA, Hodgson WC.
    Toxicol Lett; 2013 Jun 07; 219(3):262-8. PubMed ID: 23545348
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. In vitro neurotoxic and myotoxic effects of the venom from the black whip snake (Demansia papuensis).
    Kuruppu S, Fry BG, Hodgson WC.
    Clin Exp Pharmacol Physiol; 2006 Apr 07; 33(4):364-8. PubMed ID: 16620302
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the in vitro neuromuscular activity of venom from three Australian snakes (Hoplocephalus stephensi, Austrelaps superbus and Notechis scutatus): efficacy of tiger snake antivenom.
    Hodgson WC, Eriksson CO, Alewood PF, Fry BG.
    Clin Exp Pharmacol Physiol; 2003 Mar 07; 30(3):127-32. PubMed ID: 12603339
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.
    Isbister GK, Woods D, Alley S, O'Leary MA, Seldon M, Lincz LF.
    Toxicon; 2010 Aug 01; 56(1):75-85. PubMed ID: 20338189
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Isolation and pharmacological characterization of cannitoxin, a presynaptic neurotoxin from the venom of the Papuan Taipan (Oxyuranus scutellatus canni).
    Kuruppu S, Reeve S, Banerjee Y, Kini RM, Smith AI, Hodgson WC.
    J Pharmacol Exp Ther; 2005 Dec 01; 315(3):1196-202. PubMed ID: 16135698
    [Abstract] [Full Text] [Related]

  • 36. Neuromuscular activity of the venoms of the Colombian coral snakes Micrurus dissoleucus and Micrurus mipartitus: an evolutionary perspective.
    Renjifo C, Smith EN, Hodgson WC, Renjifo JM, Sanchez A, Acosta R, Maldonado JH, Riveros A.
    Toxicon; 2012 Jan 01; 59(1):132-42. PubMed ID: 22108621
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Oxylepitoxin-1, a reversible neurotoxin from the venom of the inland taipan (Oxyuranus microlepidotus).
    Clarke C, Kuruppu S, Reeve S, Ian Smith A, Hodgson WC.
    Peptides; 2006 Nov 01; 27(11):2655-60. PubMed ID: 16879898
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.